309 related articles for article (PubMed ID: 7018514)
1. Effect of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients. -I) In vitro study.
Auteri A; Laghi Pasini F; Pasqui AL; Bilenchi R; Di Perri T
Boll Soc Ital Biol Sper; 1980 Feb; 56(4):308-11. PubMed ID: 7018514
[No Abstract] [Full Text] [Related]
2. Effects of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients.-II) In vivo study.
Auteri A; Laghi Pasini F; Pasqui AL; Bilenchi R; Di Perri T
Boll Soc Ital Biol Sper; 1980 Feb; 56(4):312-5. PubMed ID: 7018515
[No Abstract] [Full Text] [Related]
3. Pharmacological induced depression of E-rosette forming cells (RFC) of normal healthy subjects. Restoration by levamisole and thymopoietin pentapeptide.
Laghi Pasini F; Auteri A; Ceccatelli L; Di Perri T
Boll Soc Ital Biol Sper; 1980 Feb; 56(4):316-22. PubMed ID: 7018516
[TBL] [Abstract][Full Text] [Related]
4. Restoration of the impaired lymphocyte stimulation in old people by thymopoietin pentapeptide.
Verhaegen H; De Cock W; De Cree J; Goldstein G
J Clin Lab Immunol; 1981 Sep; 6(2):103-5. PubMed ID: 7026790
[TBL] [Abstract][Full Text] [Related]
5. Immunokinetics of a single dose of thymopoietin pentapeptide.
Di Perri T; Laghi Pasini F; Auteri A
J Immunopharmacol; 1980; 2(4):567-72. PubMed ID: 7009760
[TBL] [Abstract][Full Text] [Related]
6. Effects of synthetic thymopoietin II fragments on E-rosette forming cells of a rheumatoid arthritis patient.
Abiko T; Onodera I; Sekino H
Chem Pharm Bull (Tokyo); 1981 Aug; 29(8):2322-9. PubMed ID: 7318039
[No Abstract] [Full Text] [Related]
7. Induction and augmentation of mitogen-induced immune interferon production in human lymphocytes by a synthetic thymopoietin pentapeptide.
Diezel W; Waschke SR; Forner K
Biomed Biochim Acta; 1984; 43(6):K9-12. PubMed ID: 6435610
[No Abstract] [Full Text] [Related]
8. Comparison of the in vitro effects of thymopoietin pentapeptide and levamisole on peripheral E-rosette forming cells.
Verhaegen H; De Cock W; De Cree J; Goldstein G
Thymus; 1980 Jan; 1(4-5):195-204. PubMed ID: 7445020
[TBL] [Abstract][Full Text] [Related]
9. Immunoregulating peptides II. In vitro effects of TP5 analogs on E-rosette formation and cell division.
Denes L; Szende B; Ember J; Major J; Szporny L; Hajos G; Nyeki O; Schon I; Lapis K; Kisfaludy L
Immunopharmacol Immunotoxicol; 1987; 9(1):1-18. PubMed ID: 3330094
[TBL] [Abstract][Full Text] [Related]
10. The effect of thymopoietin II fragments and their analogs on E-rosette forming cells in the uremic state.
Abiko T; Onodera I; Sekino H
Chem Pharm Bull (Tokyo); 1980 Aug; 28(8):2507-11. PubMed ID: 7428129
[No Abstract] [Full Text] [Related]
11. Thymopoietin to thymopentin: experimental studies.
Goldstein G; Audhya TK
Surv Immunol Res; 1985; 4 Suppl 1():1-10. PubMed ID: 2994196
[TBL] [Abstract][Full Text] [Related]
12. Effects of thymopoietin pentapeptide (TP-5) on in vitro and in vivo IgE production by atopic dermatitis cell subsets.
Cooper KD; Kang K; Hanifin JM
Diagn Immunol; 1983; 1(3):211-5. PubMed ID: 6388971
[TBL] [Abstract][Full Text] [Related]
13. Structural requirements for the biological activity of thymopentin analogs.
Heavner GA; Audhya T; Kroon D; Goldstein G
Arch Biochem Biophys; 1985 Oct; 242(1):248-55. PubMed ID: 2996431
[TBL] [Abstract][Full Text] [Related]
14. Influence of thymic hormones on mitogen-induced interferon production in lymphocytes. II. Enhancement of Con-A-induced immune interferon production by a synthetic thymopoietin pentapeptide.
Rentz E; Diezel W; Ehrlich A; Forner K
Arch Geschwulstforsch; 1984; 54(2):113-8. PubMed ID: 6329122
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and effects of two peptide fragments of thymopoietin II on E-rosette forming cells in the uremic state.
Abiko T; Kumikawa M; Sekino H
Chem Pharm Bull (Tokyo); 1979 Sep; 27(9):2233-7. PubMed ID: 519816
[No Abstract] [Full Text] [Related]
16. Effects of a synthetic extract (thymopentin) on the immune system of lepromatous leprosy patients.
Munno I; Pellegrino NM; Fumo G; Barbieri G; Polimeno G; de Filippis V; Jirillo E
Cytobios; 1987; 52(210-211):167-73. PubMed ID: 3123147
[TBL] [Abstract][Full Text] [Related]
17. Thymopoietin pentapeptide (thymopentin, TP-5) in the treatment of rheumatoid arthritis. A compilation of several short- and longterm clinical studies.
Veys EM; Mielants H; Verbruggen G; Spiro T; Newdeck E; Power D; Goldstein G
J Rheumatol; 1984 Aug; 11(4):462-6. PubMed ID: 6384507
[TBL] [Abstract][Full Text] [Related]
18. [Stimulation of immunogenesis by neurotensin, pentagastrin and thymopentin and ways of its realization].
Belokrylov GA; Molchanova IV; Popova OIa
Biull Eksp Biol Med; 1989 Nov; 108(11):584-7. PubMed ID: 2699257
[TBL] [Abstract][Full Text] [Related]
19. Arg-Lys-Asp-Val-Tyr (thymopentin) accelerates the cholinergic-induced inactivation (desensitization) of reconstituted nicotinic receptor.
Ochoa EL; Medrano S; de Carlin MC; Dilonardo AM
Cell Mol Neurobiol; 1988 Sep; 8(3):325-31. PubMed ID: 3066488
[TBL] [Abstract][Full Text] [Related]
20. The in vitro effect of the thymic factor thymopoietin on a subpopulation of lymphocytes from severely malnourished children.
Jackson TM; Zaman SN
Clin Exp Immunol; 1980 Mar; 39(3):717-21. PubMed ID: 6769624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
